Three-Dimensional-Printed Polymeric Cores for Methane Hydrate Enhanced Growth.

Polymeric models of the core prepared with a Raise3D Pro2 3D printer were employed for methane hydrate formation. Polylactic acid (PLA), acrylonitrile butadiene styrene (ABS), carbon fiber reinforced polyamide-6 (UltraX), thermoplastic polyurethane (PolyFlex), and polycarbonate (ePC) were used for printing. Each plastic core was rescanned using X-ray tomography to identify the effective porosity volumes. It was revealed that the polymer type matters in enhancing methane hydrate formation. All polymer cores except PolyFlex promoted the hydrate growth (up to complete water-to-hydrate conversion with PLA core). At the same time, changing the filling degree of the porous volume with water from partial to complete decreased the efficiency of hydrate growth by two times. Nevertheless, the polymer type variation allowed three main features: (1) managing the hydrate growth direction via water or gas preferential transfer through the effective porosity; (2) the blowing of hydrate crystals into the volume of water; and (3) the growth of hydrate arrays from the steel walls of the cell towards the polymer core due to defects in the hydrate crust, providing an additional contact between water and gas. These features are probably controlled by the hydrophobicity of the pore surface. The proper filament selection allows the hydrate formation mode to be set for specific process requirements.

Clathrate Hydrates of Organic Solvents as Auxiliary Intermediates in Pharmaceutical Research and Development: Improving Dissolution Behaviour of a New Anti-Tuberculosis Drug, Perchlozon.

There is an urgent need for new drugs to overcome the challenge of the ever-growing drug resistance towards tuberculosis. A new, highly efficient anti-tuberculosis drug, Perchlozone (thioureidoiminomethylpyridinium perchlorate, Pz), is only available in an oral dosage form, though injectable forms and inhalation solutions could be better alternatives, offering higher bioavailability. To produce such forms, nano- and micro-particles of APIs would need to be prepared as dispersions with carriers. We use this case study to illustrate the principles of selecting solvents and excipients when preparing such formulations. We justify the choice of water-THF (19.1 wt % THF) as solvent and mannitol as carrier to prepare formulations of Pz-a poorly soluble compound-that are suitable for injection or inhalation. The formulations could be prepared by conventional freeze-drying in vials, making the proposed method suitable for industrial scaling. A similar strategy for selecting the organic solvent and the excipient can be applied to other compounds with low water solubility.